drugset / Trial / NCT07691996

Effects of Melatonin on Sleep Architecture of Critically Ill Patients in the ICU

NCT07691996

Phase 4 Not yet recruiting 30 enrolled Rutgers, The State University of New Jersey
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study to examine the effects of melatonin on the sleep patterns of critically ill patients. Patients will have their sleep patterns measured with a device attached to their head with a headband then be given a dose of melatonin. Their participation in the study will last two days.

Timeline

Start
2026-09-01
Primary completion
2027-06
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 3 mg Oral

Indications

No indication recorded.